NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51167-500-02 | 51167-500 | HUMAN PRESCRIPTION DRUG | ORKAMBI | lumacaftor and ivacaftor | GRANULE | ORAL | 20180807 | N/A | NDA | NDA211358 | Vertex Pharmaceuticals Incorporated | IVACAFTOR; LUMACAFTOR | 188 mg/1; 150 mg/1 | 56 PACKET in 1 CARTON (51167-500-02) / 1 GRANULE in 1 PACKET |
51167-122-01 | 51167-122 | HUMAN PRESCRIPTION DRUG | ORKAMBI | lumacaftor and ivacaftor | GRANULE | ORAL | 20220902 | N/A | NDA | NDA211358 | Vertex Pharmaceuticals Incorporated | IVACAFTOR; LUMACAFTOR | 94 mg/1; 75 mg/1 | 56 PACKET in 1 CARTON (51167-122-01) / 1 GRANULE in 1 PACKET |
51167-900-01 | 51167-900 | HUMAN PRESCRIPTION DRUG | ORKAMBI | lumacaftor and ivacaftor | GRANULE | ORAL | 20180807 | N/A | NDA | NDA211358 | Vertex Pharmaceuticals Incorporated | IVACAFTOR; LUMACAFTOR | 125 mg/1; 100 mg/1 | 56 PACKET in 1 CARTON (51167-900-01) / 1 GRANULE in 1 PACKET |